GPX4 and melanoma: BSO reduces tumor burden in mice and improves the susceptibility of melanoma and neuroblastoma cells to chemotherapy by inhibiting glutathione synthesis rate-limiting enzyme (GCL), inactivating GPX4, and inducing cell death [136, 137].